Keyphrases
Dentate nucleus
56%
Magnetic Resonance Imaging
56%
18F-FDG PET-CT
50%
Sinonasal Malignancy
37%
Gadobutrol
36%
Macrocyclic Gadolinium-based Contrast Agents
35%
Gadolinium-based Contrast Agents
34%
Signal Intensity Ratio
32%
Pediatric
29%
Whole-body
28%
Globus Pallidus
28%
Glioblastoma
28%
FDG PET-CT
28%
SUVmax
24%
Diffusion-weighted Imaging
23%
Signal Intensity Change
21%
Adenoid Cystic Carcinoma
21%
Fluid-attenuated Inversion Recovery (FLAIR)
20%
Computed Tomography
20%
Sinonasal Neoplasms
20%
Survival Prediction
18%
Neuroimaging
18%
Susceptibility-weighted Imaging
18%
Pneumothorax
18%
Genetic Modification
18%
Chest Tube Drainage
18%
T1-weighted
18%
Repeated Administration
18%
Computed Tomography-guided
18%
Diffusion-weighted MR Imaging
18%
Liver
17%
SUV Ratio
16%
Head Computed Tomography
15%
Image Features
15%
Imaging Findings
15%
Agent Group
14%
Middle Cerebellar Peduncle
14%
Tuberculum Sellae
14%
Multiparametric MRI (mpMRI)
14%
Predictor Variables
13%
Brain Tumor
13%
Standardized Uptake Value
13%
T1-weighted MRI
13%
T1-weighted Imaging
13%
Signal Change
12%
Distant Metastasis
12%
Emergency Department
12%
Sinonasal
12%
Core Needle
12%
Lung Biopsy
12%
Medicine and Dentistry
Magnetic Resonance Imaging
100%
Positron Emission Tomography-Computed Tomography
68%
Computer Assisted Tomography
60%
Neoplasm
54%
Fluorodeoxyglucose F 18
37%
Diffusion MRI
35%
Cancer
34%
Magnetic Resonance Imaging
29%
Fluorine-18
28%
Glioblastoma
28%
Gadolinium
28%
Dentate Nucleus
25%
Contrast Medium
25%
Cylindroma
24%
Intracranial Tumor
21%
Pediatrics
21%
Biopsy Technique
19%
Pneumothorax
18%
Adrenoleukodystrophy
18%
Perfusion Weighted Imaging
18%
Proton Nuclear Magnetic Resonance
18%
Multiparametric Magnetic Resonance Imaging
18%
Gadobutrol
18%
Chest Tube
18%
Sella turcica
16%
Globus pallidus
15%
Radiology
14%
Progression Free Survival
14%
Standardized Uptake Value
13%
Overall Survival
12%
Emergency Department
12%
Differential Diagnosis
12%
Lung Biopsy
12%
Metastatic Carcinoma
12%
Malignant Neoplasm
12%
Isocitrate Dehydrogenase 1
11%
Biological Marker
11%
Distant Metastasis Free Survival
10%
Positron Emission Tomography
10%
Protein P53
10%
Lung Lesion
10%
Needle Biopsy
10%
Epileptic Seizure
10%
Distant Metastasis
9%
Radiomics
9%
Bleeding
9%
Papillary Carcinoma
9%
Susceptibility Weighted Imaging
9%
Radiation Therapy
9%
Ganglioglioma
9%